StemBioSys is a stem cell therapeutics development company using novel, patented extracellular matrix technology to provide proprietary stems cells for collaborative and in-house therapeutic solutions.

The extracellular matrix (ECM) technology pioneered by StemBioSys enables the clinician to obtain and greatly multiply human non-embryonic stem cells that exhibit a very high degree of potency. The ECM is a 3D matrix laid down by bone marrow cells that is similar to the native environment of stem cells and can enable the production of significantly more cells of higher quality than existing methodology.

The StemBioSys team is greatly augmented by the addition of Dr. Robert Langer, MIT Professor, as a director and as Chair of the Scientific Advisory Board. Dr. Langer’s lab at MIT is the largest biomedical engineering lab in the world, and he is one of the most widely referenced and awarded engineers alive today.